NCT00358696View on ClinicalTrials.gov

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
HIVHIV Infections
Interventions
DRUG

tenofovir

See Detailed Description.

Trial Locations (1)

Unknown

Pender Community Health Centre, Vancouver

Sponsors

Collaborators (1)

Health Canada
All Listed Sponsors
collaborator

Health Canada

OTHER_GOV

lead

University of British Columbia

OTHER

NCT00358696 - Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients | Biotech Hunter | Biotech Hunter